Introduction
============

The tumor-node-metastasis (TNM) classification is a widely accepted system for estimating the prognosis in various types of cancer ([@b1-ol-0-0-8951],[@b2-ol-0-0-8951]). The TNM staging system in head and neck squamous cell carcinoma (SCC), including oral SCC, is reported to be unable to predict the survival outcomes of patients at the same stage ([@b2-ol-0-0-8951]--[@b4-ol-0-0-8951]). Numerous studies have researched the prognostic parameters of oral SCC using various approaches, including clinical and pathological procedures ([@b5-ol-0-0-8951]--[@b8-ol-0-0-8951]). The pathological tumor volume (PTV) of the primary tumor is calculated after surgical resection by measuring its diameters in three dimensions ([@b9-ol-0-0-8951]--[@b13-ol-0-0-8951]). Recently, the PTV in tongue SCC, which is part of the oral cavity, was reported to be significantly correlated with the survival outcome ([@b9-ol-0-0-8951]). However, to the best of our knowledge, the association between the PTV and overall survival in patients with SCC of the entire oral cavity has not been investigated.

In the present study, we investigated the possible association between the PTV and overall survival in patients with both oral SCC and clinical lymph node metastasis.

Materials and methods
=====================

### Patients and methods

From January 2008 to December 2013, 56 patients, who were newly diagnosed with oral cancer with clinical lymph node metastasis, underwent surgery without preoperative treatment at the Department of Head and Neck Surgery, Aichi Cancer Center Hospital. We excluded six patients with histological types other than SCC, one patient with carcinoma *in situ* of the primary site, one patient with synchronous colon cancer, and one patient in whom it was not possible to define a theoretically reconstructed normal mucosal line in the pathological examination. Thus, a total of 47 patients were enrolled in this study. The sites of the primary tumor were as follows: Tongue, n=29; lower gum, n=6; upper gum, n=5; floor of mouth, n=3; buccal mucosa, n=2; and hard palate, n=2. This study was approved by the institutional review board, and all patients provided their informed consent for all of the examinations and treatments. The clinical stage was determined by physical examinations and enhanced cervical computed tomography, ^18^F-fluorodeoxyglucose-positron emission tomography with computed tomography or magnetic resonance imaging. The TNM classification system of the International Union Against Cancer (seventh edition) was used for the staging of the tumors ([@b14-ol-0-0-8951]). Surgically resected tissues were fixed with formalin and embedded in paraffin. Representative sections of the paraffin-embedded tissues were cut and stained with hematoxylin and eosin. The pathological examinations were performed by two experienced pathologists.

### The measurement of the pathological parameters

The tumor size was defined as the greatest dimension of the primary tumor, as measured in the pathological examination. The tumor thickness, depth of invasion, and PTV were measured as described previously ([@b7-ol-0-0-8951],[@b10-ol-0-0-8951]). Both the tumor thickness and the depth of invasion were measured by microscopic examinations using an ocular micrometer with an accuracy of 0.1 mm. The tumor thickness was assessed as the distance from the surface of the tumor to the site that showed the deepest invasion. The depth of invasion was measured as the distance from the theoretically reconstructed normal mucosal line to the site that showed the deepest invasion. The PTV was calculated using the following formula: PTV=π/6 \*(X~path~x Y~path~x Z~path~). Both X~path~ and Y~path~ were obtained from the pathological report, and Z~path~ was assessed by the tumor thickness. A representative image from the pathological examination is shown in [Fig. 1](#f1-ol-0-0-8951){ref-type="fig"}.

### Statistical analysis

All of the statistical analyses were performed using the JMP software program (version 11; SAS; Cary, NC, USA). The relationships between the PTV and the clinicopathological parameters (gender, age, tumor site, pathological T classification, pathological N classification, pathological stage, positive surgical margin, extracapsular extension, postoperative radiation, and positive surgical margin and/or extracapsular extension) were analyzed using a t-test, Mann-Whitney U test, or Kruskal-Wallis test, as appropriate. The relationships between the PTV and the pathological parameters (size, tumor thickness, and depth of invasion) were assessed by a simple regression analysis. The Kaplan-Meier method was used to estimate the survival time. We defined the survival time as the period from surgery to a target event or last contact. The target events included death (for overall survival), local recurrence (for local recurrence-free survival), regional recurrence (for regional recurrence-free survival), and distant metastasis (for distant metastasis-free survival) ([@b15-ol-0-0-8951]). Applying a modification of a previously described method ([@b15-ol-0-0-8951],[@b16-ol-0-0-8951]), various PTV cut-off values were tested using a Cox proportional hazards model of univariate overall survival. Since a PTV of 18 cm^3^ was found to significantly differentiate the shorter survival group from the longer survival group in the univariate analysis of overall survival, all of the patients were separated into two groups based on the PTV (PTV \<18 cm^3^ or PTV ≥18 cm^3^). The relationship between both the clinicopathological parameters and the pathological parameters in these two groups was compared using the chi-squared test and the Mann-Whitney U test. The two groups (PTV \<18 cm^3^ and PTV ≥18 cm^3^) were compared by univariate analyses of local recurrence-free survival, regional recurrence-free survival, and distant metastasis-free survival. We performed multivariate analyses (overall survival and local recurrence-free survival) with adjustments for the primary site (tongue/others), pathological stage (stage I--II/stage III--IV), and positive surgical margin and/or extracapsular extension (absent/present) using a Cox proportional hazards model. P-values of \<0.05 were considered to indicate statistical significance.

Results
=======

### The PTV and the clinicopathological parameters

The mean ± standard deviation PTV of the whole study population was 10.30±12.03 cm^3^. The associations between the PTV and the clinicopathological parameters are shown in [Table I](#tI-ol-0-0-8951){ref-type="table"}. The PTV was significantly correlated with the pathological T classification (P\<0.01), pathological stage (P\<0.02), and a positive surgical margin (P\<0.03).

### The PTV and the pathological parameters

A simple regression analysis was performed to analyze the associations between the PTV and the pathological parameters ([Fig. 2](#f2-ol-0-0-8951){ref-type="fig"}). The PTV was significantly correlated with the size (r=0.82, P\<0.01), tumor thickness (r=0.87, P\<0.01), and depth of invasion (r=0.62, P\<0.01).

### The clinical course

The median follow-up period was 23 months (range 3--77 months). Eighteen of the overall patients (38.3%) died before the end of the study. Nine (19.1%, vs. all), 10 (21.3%, vs. all), and 10 (21.3%, vs. all) patients exhibited local recurrence, regional recurrence, and distant metastasis, respectively. At the end of the study, the rates of overall survival, local recurrence-free survival, regional recurrence-free survival, and distant metastasis-free survival in the whole study population were 58.5, 78.2, 37.8, and 74.4%, respectively.

### The univariate survival analysis

Various cut-off PTV values were tested using a Cox proportional hazard model in the univariate analysis of overall survival, and a PTV of 18 cm^3^ was found to have the lowest P-value ([Fig. 3](#f3-ol-0-0-8951){ref-type="fig"}). The univariate analysis of overall survival revealed that a PTV of 18 cm^3^ significantly differentiated the shorter overall survival group (PTV ≥18 cm^3^) from the longer overall survival group (PTV \<18 cm^3^). The Kaplan-Meier curves from the univariate overall survival analysis are shown in [Fig. 4](#f4-ol-0-0-8951){ref-type="fig"}. The correlation of both the clinicopathological parameters and the pathological parameters between the two groups (PTV ≥18 cm^3^; PTV \<18 cm^3^) is shown in [Table II](#tII-ol-0-0-8951){ref-type="table"}. A PTV of ≥18 cm^3^ was more frequently found in patients with a pathological T classification of 3--4 (P\<0.01), who had received postoperative radiation (P\<0.01), who showed a positive surgical margin (P\<0.01), and who showed a positive surgical margin and/or extracapsular extension (P\<0.02). A PTV of ≥18 cm^3^ was significantly correlated with larger size (P\<0.01), tumor thickness (P\<0.01), and the depth of invasion (P\<0.01). The patients with a PTV of ≥18 cm^3^ showed significantly shorter local recurrence-free survival than those with a PTV of \<18 cm^3^ (P\<0.01). However, the patients with PTV of ≥18 cm^3^ did not show shorter regional recurrence-free survival (P=0.58), or distant metastasis-free survival (P=0.24). The Kaplan-Meier curves from the univariate analysis of the local recurrence-free survival are shown in [Fig. 5](#f5-ol-0-0-8951){ref-type="fig"}.

### The multivariate survival analyses

We performed multivariate analyses of overall survival and local recurrence-free survival with adjustments for the primary site, pathological stage, and positive surgical margin and/or extracapsular extension ([Table III](#tIII-ol-0-0-8951){ref-type="table"}). A PTV of ≥18 cm^3^ was significantly associated with shorter overall survival (P\<0.01) and local recurrence-free survival (P\<0.01) in the multivariate analysis.

Discussion
==========

The results of the using univariate and multivariate analyses in the present study showed-for the first time-that a PTV of ≥18 cm^3^ was significantly associated with shorter overall survival and local recurrence-free survival in patients with oral SCC.

Both the depth of invasion and the tumor thickness were considered representative prognostic parameters for oral SCC ([@b6-ol-0-0-8951],[@b7-ol-0-0-8951]). In a review of 55 clinical studies, both the depth of invasion and the tumor thickness were significantly correlated with overall survival in oral SCC ([@b6-ol-0-0-8951]). Indeed, the significant correlation between overall survival and these pathological parameters (tumor thickness and depth of invasion) that was found in our previous and present studies was in good agreement with previous findings ([@b6-ol-0-0-8951],[@b7-ol-0-0-8951]).

The PTV, which is calculated by three-dimensional measurements, has been reported as a pathological parameter in various sites of cancer ([@b9-ol-0-0-8951]--[@b13-ol-0-0-8951]). Mucke *et al* ([@b9-ol-0-0-8951]) showed a significant correlation between a larger PTV and shorter overall survival in 437 patients with tongue SCC. We have also reported on the PTV in hypopharyngeal SCC ([@b10-ol-0-0-8951]). We hypothesized that a larger PTV would be related to shorter overall survival in patients with SCC of the entire oral cavity. The significant correlation between the PTV and overall survival in the present study supported this hypothesis.

In a previous study about the PTV in tongue SCC ([@b9-ol-0-0-8951]), the rate of local recurrence-free survival was not estimated. For the first time, we demonstrated that a PTV of ≥18 cm^3^ is significantly associated with shorter local recurrence-free survival. The result suggests that postoperative therapy, such as chemoradiotherapy has the potential to improve local recurrence-free survival in patients with a PTV of ≥18 cm^3^. Furthermore, we demonstrated-for the first time-that the PTV in oral SCC is significantly correlated with the pathological parameters (size, tumor thickness, and depth of invasion).

The extracapsular extension is considered a significant prognostic factor in head and neck cancer, including oral cancer ([@b8-ol-0-0-8951]). In the present study, the PTV was not correlated with the extracapsular extension in [Tables I](#tI-ol-0-0-8951){ref-type="table"} and [II](#tII-ol-0-0-8951){ref-type="table"}, and the patients with a PTV of ≥18 cm^3^ did not show a shorter regional recurrence-free survival than those with a PTV of \<18 cm^3^ (P=0.58). We believe that this fundamental difference in the prognostic utility of PTV and extracapsular extension may have been because PTV was a prognostic factor obtained from the primary tumor, while extracapsular extension was a prognostic factor obtained from the cervical lymph node.

We showed the results of multivariate analyses which were adjusted by the Cox proportional hazards model in the present study. We considered PTV not to be an independent prognostic factor, although it was a prognostic factor in multivariate analyses after adjustments were made for the primary site, pathological stage, and positive surgical margin and/or extracapsular extension. To exclude the influence of the confounding factors, we underwent the multivariate analyses in the present study. Since PTV was significantly associated with pathological T classification, pathological stage, positive surgical margin, size, tumor thickness, and depth of invasion in the present study, we considered that PTV is not an independent prognostic factor.

The present study is associated with some limitations, including the relatively small study population and its retrospective nature. A future prospective analysis of a larger study population will yield more accurate results and will hopefully provide insight into the potential application of the PTV as a prognostic tool.

In conclusion, we demonstrated, for the first time, that a PTV of ≥18 cm^3^ was significantly correlated with shorter overall survival and local recurrence-free survival in patients with SCC of the entire oral cavity. Thus, these results suggest that the PTV is a prognostic parameter in oral SCC.
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PTV

:   pathological tumor volume

SCC

:   squamous cell carcinoma

TNM

:   tumor-node-metastasis

![Tumor thickness between arrowheads and depth of invasion between arrows were measured during a microscopic examination of hematoxylin and eosin stained sections using an ocular micrometer. Scale bar=5 mm. The tumor thickness was assessed as the distance from the surface of the tumor to the deepest invasion. The depth of invasion was measured as the distance from the theoretically reconstructed normal mucosal line to the deepest invasion.](ol-16-02-2471-g00){#f1-ol-0-0-8951}

![Relationship between (A) the pathological tumor volume and size, (B) the pathological tumor volume and the tumor thickness and (C) the pathological tumor volume and the depth of invasion among 47 patients with oral squamous cell carcinoma in a simple regression analysis.](ol-16-02-2471-g01){#f2-ol-0-0-8951}

![P-values of the univariate Cox proportional hazard model. To determine the factors associated overall survival using different cut-off pathological tumor volume values in 47 patients with oral squamous cell carcinoma, P-values of the univariate Cox proportional hazard model were compared. A pathological tumor volume of 18 cm^3^ had the lowest P-value (9.94×10^−5^; arrow).](ol-16-02-2471-g02){#f3-ol-0-0-8951}

![Kaplan-Meier analysis of overall survival. A pathological tumor volume of ≥18 cm^3^ was associated with significantly shorter overall survival (P\<0.01).](ol-16-02-2471-g03){#f4-ol-0-0-8951}

![Kaplan-Meier analysis of local recurrence-free survival. A pathological tumor volume of ≥18 cm^3^ was associated with a significantly shorter local recurrence-free survival (P\<0.01).](ol-16-02-2471-g04){#f5-ol-0-0-8951}

###### 

Association between pathological tumor volume and clinicopathological parameters (n=47).

  Parameter                                                 Number   PTV (Mean ± standard deviation cm^3^)   P-value
  --------------------------------------------------------- -------- --------------------------------------- -----------------------------------------------------
  Age                                                                                                        0.61ª
    \<64                                                    23         9.37±12.30                            
    ≥64                                                     24       11.20±11.96                             
  Sex                                                                                                        0.57^[b](#tfn3-ol-0-0-8951){ref-type="table-fn"}^
    Male                                                    25       12.53±14.28                             
    Female                                                  22       7.77±8.44                               
  Site                                                                                                       0.68ª
    Tongue                                                  29         9.73±11.34                            
    Others                                                  18       11.24±13.35                             
  Pathological T classification                                                                              \<0.01^[c](#tfn4-ol-0-0-8951){ref-type="table-fn"}^
    T1                                                      5        0.71±0.69                               
    T2                                                      22       5.33±3.71                               
    T3                                                      9        16.96±9.65                              
    T4                                                      11       19.16±18.31                             
  Pathological N classification                                                                              0.58^[c](#tfn4-ol-0-0-8951){ref-type="table-fn"}^
    N0                                                      14         8.35±10.09                            
    N1                                                      5        5.43±3.86                               
    N2                                                      28       12.15±13.61                             
  Pathological stage                                                                                         \<0.02^[c](#tfn4-ol-0-0-8951){ref-type="table-fn"}^
    I                                                       3        0.37±0.16                               
    II                                                      6        4.14±2.61                               
    III                                                     7        8.91±5.96                               
    IV                                                      31       12.77±13.76                             
  Radiation therapy                                                                                          0.52^[b](#tfn3-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  31       7.90±8.00                               
    Present                                                 16       14.97±16.75                             
  Extracapsular extension                                                                                    0.51^[a](#tfn2-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  33       9.50±11.28                              
    Present                                                 14       12.11±13.92                             
  Positive surgical margin                                                                                   \<0.03^[b](#tfn3-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  38       7.71±8.73                               
    Present                                                 9        21.27±17.68                             
  Positive surgical margin and/or extracapsular extension                                                    0.38^[b](#tfn3-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  29       8.01±8.97                               
    Present                                                 18       14.00±15.35                             

PTV, pathological tumor volume.

t-test.

Mann-Whitney U test.

Kruskal-Wallis test.

###### 

Association of clinicopathological parameters and continuative pathological parameters with PTV (\<18 cm^3^/≥18 cm^3^).

  Parameter                                                 PTV \<18 cm^3^ (n=39)   PTV ≥18 cm^3^ (n=8)   P-value
  --------------------------------------------------------- ----------------------- --------------------- -----------------------------------------------------
  Age                                                                                                     0.48^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    \<64                                                    20                      3                     
    ≥64                                                     19                      5                     
  Sex                                                                                                     0.17^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    Male                                                    19                      6                     
    Female                                                  20                      2                     
  Site                                                                                                    0.45^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    Tongue                                                  25                      4                     
    Others                                                  14                      4                     
  Pathological T classification                                                                           \<0.01^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    T1-2                                                    27                      0                     
    T3-4                                                    12                      8                     
  Pathological N classification                                                                           0.24^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    N0                                                      13                      1                     
    N1-2                                                    26                      7                     
  Pathological stage                                                                                      0.13^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    I--II                                                   9                       0                     
    III--IV                                                 30                      8                     
  Radiation therapy                                                                                       \<0.01^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  29                      2                     
    Present                                                 10                      6                     
  Extracapsular extension                                                                                 0.17^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  29                      4                     
    Present                                                 10                      4                     
  Positive surgical margin                                                                                \<0.01^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  35                      3                     
    Present                                                 4                       5                     
  Positive surgical margin and/or extracapsular extension                                                 \<0.02^[a](#tfn6-ol-0-0-8951){ref-type="table-fn"}^
    Absent                                                  27                      2                     
    Present                                                 12                      6                     
  Size (mm)                                                                                               \<0.01^[b](#tfn7-ol-0-0-8951){ref-type="table-fn"}^
    Mean ± standard deviation                               29.56±9.97              55.50±6.63            
  Tumor thickness (mm)                                                                                    \<0.01^[b](#tfn7-ol-0-0-8951){ref-type="table-fn"}^
    Mean ± standard deviation                               14.15±5.77              31.32±4.32            
  Depth of invasion (mm)                                                                                  \<0.01^[b](#tfn7-ol-0-0-8951){ref-type="table-fn"}^
    Mean ± standard deviation                               13.07±6.70              28.95±13.16           

PTV, pathological tumor volume.

Chi-square test.

Mann-Whitney U test.

###### 

Multivariate analysis of overall survival and local recurrence-free survival.

                                                            Overall survival   Local recurrence-free survival                                 
  --------------------------------------------------------- ------------------ -------------------------------- -------- ------ ------------- --------
  Primary site                                                                                                  0.07                          0.35
    Tongue                                                  1                                                            1                    
    Others                                                  0.38               0.12--1.08                                1.87   0.50--7.83    
  Pathological stage                                                                                            0.12                          0.94
    I--II                                                   1                                                            1                    
    III--IV                                                 3.98               0.73--74.07                               1.09   0.15--22.03   
  Positive surgical margin and/or extracapsular extension                                                       0.44                          0.59
    Absent                                                  1                                                            1                    
    Present                                                 1.57               0.49--4.92                                0.66   0.14--3.03    
  PTV                                                                                                           \<0.01                        \<0.01
    \<18 cm^3^                                              1                                                            1                    
    ≥18 cm^3^                                               8.30               2.46--29.45                               8.54   1.81--44.72   

PTV, pathological tumor volume; HR, hazard ratio; CI, confidence interval.
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